Java Advanced Training shows developers how to expand their programming skills and get more out of Java This course offers platform and frameworkneutral tutorials that can be used to build web mobile ...
Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback